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Urocanic Acid and UV-Induced Herpes Simplex 
When mice are exposed to ultraviolet (UV) irrad iation , their de-
layed-type hypersensitivity response to herpes si mplex virus is 
suppressed. "So," says Mary N orval of the Uni versity of Edin-
burgh M edical School, "we asked how ultraviolet lig ht mediates 
that immuno-suppressive effect." In this issue, N orval, J ames 
Ross, Sa rah H owie, J ean Mainga y, and T hom as Simpson report 
that the UV -induced immuno-suppressive effect occurs through 
urocanic acid, a m ajor component of the stratum corneum . This 
may account for the common cl inical o bservation of fever blisters 
being activated by sunlight. 
Urocanic acid norm ally is in the trans form , but once it is 
irradiated, it converts to the cis form . If urocanic acid is an im-
m une modulator fo llowin g UV irradiation , the researchers 
reasoned, then it most likely is the cis form that is active. To test 
this hypothesis, N orval and her associates began their study by 
irradiatin g urocanic acid , th ereby converting about 25% of it to 
the cis form. 
T hey painted the irrad iated urocani c acid onto the skin of mi ce 
or they inj ected it subcutaneously. In either case, the substance 
suppressed the del ayed hypersensitivity response to herpes sim-
plex to the sa me extent as it is suppressed in irradiated mi ce. " It 
seems as though ultravio let li gh t and cis urocani c acid are doin g 
the same thing in mi ce, " N orva l rem arks. 
N ow the resea rchers are asking how and where cis urocanic 
acid is acting. In particul ar, they want to learn which popul ation 
of immune cells is affected by uroca nic acid, and by w hat m ech-
alllsm . 
Why Keratinocytes May Express HLA-DR 
Normall y, the on ly skin cells to express HLA-DR anti gens (the 
histocompatibi lity antigens) are Langerhans cells and indetermi-
nate cells. But in so m e diseases-characterized by infiltrates of 
monon uclear cells in the skin-keratinocytes express these anti-
gen s. So, the question is, how and why do HLA-DR antigens 
appear on keratinocy tes? In this issue, N orman Wikner, J. C lark 
Huff, David N orris, Steven Boyce, Matthew Ca ry , M ark Kis-
singer, and Willi am Wes ton of the Uni versity of Colo rado Hea lth 
Sciences Center use an in vitro assay to provide a partial answer. 
T he diseases in w hich keratinocy tes ex press HLA-DR antigens 
include graft versus host disease, lichen planus, mycosis fun-
goides , and skin g raft rejection . In each of these diseases , says 
Wikner, "mononuclear cells are present in the skin and are pre-
sumed to be pathologica lly involved ." T he two hypotheses to 
explain the presence of HLA-DR antigens on keratinocy tes of 
patients with these diseases postulate a role for the m ononuclear 
celJ s. One hypothesis is that the m ononuclear cells stimulate ke-
ratinocytes to express these antigens. T he other is that HLA-DR 
antigens from m ononuclear cells are transferred to keratin ocytes. 
To examine these hypotheses , Wikner and his associa tes made 
use of pure keratinocyte cultures that they grew in a serum-free, 
completely defined medium. Their objective, says Wikn er, w as 
"to try and fi gure out if we could va ry the cul ture medium to 
get keratinocytes to express HLA-DR. " T hey bega n by varying 
the calcium concentrations, adding fetal calf serum, adding nor-
mal human serum, adding nonspecifi c mitogens from plants that 
cause cells to proliferate, and adding a facto r from keratinocytes-
epidermal thymocy te activating facto r-that is similar to inter-
leukin-l. N one of these manipulations induced the cultured ke-
ratinocytes to express HLA-DR. 
N ext, Wikner and his colleagues added peripheral blood mono-
nuclear cells to the keratinocyte culture. Still , there was no expres-
sion of HLA-DR antigens. Finally, they added concanavalin A 
to the system , and the keratinocytes ex pressed HLA-DR antigens. 
But , says Wikner, " this depended on the monon uclea r cells being 
added. It seem ed to be due to the m ononuclear cc;lIs. " So the 
in vestiga tors added the supernatant from the concanavalin A-
stimulated mononucl ear cells to the cul tured keratinocytes to see 
if a factor secreted from the mo nonucl ear cells was respo nsible 
fo r this effect. T he keratinocy tes expressed HLA- DR antigens 
w hen exposed onl y to the supern atant. What the secreted factor 
m ay be is unknown, but st imulated m ononuclear cells produce 
y-interferon, interleukin- l, and interleukin-2, notes Wikner. After 
tes tin g all 3 substances, the researchers found th at onl y y-inter-
feron stimulated HLA-DR expression by the cultured keratino-
cy tes. To confirm these find in gs, they added antibodies to y-
interferon and found that they then prevented the expression of 
HLA-DR by the cultured keratinocytes . 
But Wikner an d his associates had been using immuno flu ores-
cence to assess HLA-DR expression . " Immuno flu o rescence re-
sults are always less vigorous proof than actuall y isolatin g the 
HLA-DR antigen," Wikner says. So the resea rchers used a m ore 
precise immunoprecipitatioll technique to determ ine that what 
was being expressed by the keratinocytes was, in fact, HLA-DR. 
Mo reover, they learned, th e amount of HLA-DR synthesis is 
directly related to the am ount of y-interferon present, and the 
amount of HLA-DR m ade by the keratinocytes is never as much 
as the am ount m ade by m onocytes. 
Wikner is satisfied that these ex perim ents show that ke rati no-
cytes are stimulated to make HLA-DR by y-interferon that is 
produced by stimulated m ononuclea r cells. But, he rem arks, the 
challenge now is to determine the functiona l significance of the 
y-interferon induced HLA-DR effect. " What is the role of the 
expressIon o f HLA-DR by keratin ocytes in these diseases?" he 
asks. 
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Proteinase Inhibitor in Blister Fluids 
Proteinases, collagenase, and elastase, in particular, are well known 
to be present in blister fluid s and are tho ught to play a role in 
tissue destru cti on. But , says H o w ard Wei gus o f the Jewish Hos-
pital at Washin gton Un viersity Medical Center, resea rchers have 
no t loo ked fo r inhibi to rs of proteinases in blister fluid s. Now he 
and his colleagues, Eugene Bauer and Geo rge Stri cklin , repo rt 
th at a coll agenase inhibitor is present in fluid s from blisters in-
du ced b y ph ysical and immuno logical mechanism s. 
In general, Welgus points o ut, active pro teinases are no t often 
fo und al one but arc detected in associati on with proteinase in-
hi bito rs. So it m ade sense, he and his colleagues reasoned , to loo k 
fo r such inhibito rs in blister fluid s in conditions in which acti ve 
proteinases may playa pathogeni c ro le. T he presence o f the hu-
man collagenase inhibitor has been well studied and the inhibitor 
has been detected in cultures o f hum an lun g, ging iva l and corneal 
fibro blasts, uterine sm oo th muscle cells, and tendon and ca rtilage 
ex plants. Since th e inhibito r has been purified to hom ogeneity 
and an antibod y to the inhibito r is avail able, Wclg us, Bauer, and 
Stri cklin decided to assay in o rder to detect the collagenase in-
hibito r in blister fluid s. 
They were no t surprised to find this inhibito r in bliste r fluids, 
says Wclg us, but "what surprised us w ere the levels of the in-
hibito r. " T he inhibito r w as present in concentrations 1 0-20 times 
grea ter th an found in plasm a. 
" Thi s is a preliminary report, " Welgus remarks. " W e are no t 
sure exactly w hat it m ea ns. But people have solely concentrated 
on the ro le o f ac tive proteinases in th e pathogenesis o f bliste ring 
diseases. We have sho wn that the pa thogenesis of blistering dis-
eases is more com plica ted th an th at." 
Regulating Sterol Synthesis in the Skin 
Kenn eth Feingold and his co lleagues at the Veterans Adminis-
tration Medi ca l Center in San Francisco have been interes ted for 
so m e tim e in wh at regul ates stero l synthesis in the epiderm is. " I f 
you treat the skin w ith acetone or detergents and so alter the 
skin 's perm ea bility barrier, stero l synthesis increases," Feingold 
remarks. 
B ut these chemical m ethods of alterin g epidermal permeability 
arc of questio nable va lue because the very m eth ods o f breakin g 
the skin could be affectin g sterol sy nthes is. So Feingo ld and his 
colleagues Ba rbara B ro wn, Steven Lear, Arthur Moser, and Peter 
Eli as in ves ti ga ted cutaneous stero l synthesis in essenti al fa tty acid-
de fi cient hairless mice-animals w hose genetic defi ciency results 
in excess epiderm al wa ter loss. T hey repo rt their res ults in this 
Issue. 
T hey found , says Feingold, that stero l synth esis in tile epider-
mis is indeed affected by the skin 's perm ea bili ty barrier. E pider-
m al sterol synthesis in the fa tty acid-defi cient mi ce was twice that 
o f contro ls, and when th e anim als ' essential fa tty acid defi ciency 
w as co rrected , their sterol synthesis declined. Finall y- and m ost 
convin cin gly, accordin g to Feingold-when the in ves ti ga to rs 
co rrected the animal s' perm ea bility barrier by using a plastic 
g lo velike artifi cial skin, ste rol sy nthes is declined to the normal 
range. 
Feingold concludes that the res ults sugges t that alteratio ns in 
perm ea bility affect the synthesis o f mo lecules. It is "an interes ting 
concept," he rem arks. " The fl o w o f m aterial thro ugh the skin 
influences what keratinocytes do in a feed-back mechanism. There 
is a direct link between a fund amental process, such as wa ter 
transport, and sterol synthesis. The fa tty acid-deficient mice model 
is a very interes tin g system fo r studyin g these pheno mena. " 
